E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/19/2006 in the Prospect News Biotech Daily.

Kensey Nash: first-quarter revenue up 28%, earnings per share rise 57%

By Lisa Kerner

Charlotte, N.C., Oct. 19 - Kensey Nash Corp. said its revenue increased by 28% to $16.3 million for the first quarter of fiscal 2007 from $12.7 for the first quarter of fiscal 2006.

Earnings per share rose by 57% to $0.11 for the quarter ended Sept. 30, including $0.04 per share of equity compensation expense.

The company also reported a 41% increase in net sales to $10.6 million for the quarter from $7.5 million for the prior-year quarter.

For the first quarter of fiscal 2007, pro forma income from operations was $2 million, compared with $800,000 for the same period of 2005.

The company had $29.2 million of cash, cash equivalents and investments at Sept. 30, compared with $27.2 million at June 30.

"Over the last several months we have achieved successful commercialization of multiple new spine products, which bodes well for our long-term outlook," president and chief executive officer Joe Kaufmann said in a company news release.

"We were also pleased to see that Angio-Seal component sales were a major contributor during the quarter, due to the ongoing strength of end-user sales."

The Exton, Pa., medical technology company expects second-quarter net sales to be between $11.4 million and $12.2 million and revenues to be between $17.4 million and $18.4 million.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.